Edmonds Duncan Registered Investment Advisors, LLC Erasca, Inc. Transaction History
Edmonds Duncan Registered Investment Advisors, LLC
- $410 Million
- Q2 2024
A detailed history of Edmonds Duncan Registered Investment Advisors, LLC transactions in Erasca, Inc. stock. As of the latest transaction made, Edmonds Duncan Registered Investment Advisors, LLC holds 34,280 shares of ERAS stock, worth $88,785. This represents 0.02% of its overall portfolio holdings.
Number of Shares
34,280
Previous 24,280
41.19%
Holding current value
$88,785
Previous $50,000
60.0%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ERAS
# of Institutions
133Shares Held
205MCall Options Held
3.1KPut Options Held
142K-
Frazier Life Sciences Management, L.P. Menlo Park, CA16.2MShares$42 Million2.26% of portfolio
-
Vr Adviser, LLC New York, NY16.2MShares$42 Million4.2% of portfolio
-
Suvretta Capital Management, LLC New York, NY13.8MShares$35.7 Million1.36% of portfolio
-
Arch Venture Management, LLC Chicago, IL11.1MShares$28.6 Million15.29% of portfolio
-
Black Rock Inc. New York, NY10.6MShares$27.5 Million0.0% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $316M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...